BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1377462)

  • 1. [Staging evaluation and surveillance in tumors of the testicle].
    Pabot du Chatelard P; Cordoliani Y; Merrer J
    Ann Urol (Paris); 1992; 26(2):90-102. PubMed ID: 1377462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
    Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
    Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Imaging of testicular tumors].
    Thoumas D; Caty A; Gobet F; Lemaître L
    J Radiol; 2002 Jun; 83(6 Pt 2):883- 93, discussion 894-6. PubMed ID: 12218862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum markers in germ cell neoplasms.
    Bartlett NL; Freiha FS; Torti FM
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1245-60. PubMed ID: 1723408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atypical symptoms in patients with germinal testicular tumors].
    Dieckmann KP; Krain J; Gottschalk W; Büttner P
    Urologe A; 1994 Jul; 33(4):325-30. PubMed ID: 7524231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour markers in testicular tumours.
    Chisholm GD
    Prog Clin Biol Res; 1985; 203():81-91. PubMed ID: 2421346
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-HCG positive seminoma--incidence with special reference to tumor marker concentration in testicular venous blood].
    Mumperow E; Kressel K; Hartmann M
    Urologe A; 1991 Mar; 30(2):114-6; discussion 117. PubMed ID: 1711727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of pre-orchidectomy serum tumor markers in non seminomatous germ cell tumors of the testis (N.S.G.C.T.T.).
    Boccon-Gibod L; Le Doze H; Steg A
    Prog Clin Biol Res; 1985; 203():93-5. PubMed ID: 2421347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of tumor markers in the treatment of germ cell tumors].
    Germá Lluch JR; García del Muro X; Galán MC
    Arch Esp Urol; 2000; 53(6):460-8. PubMed ID: 11002513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Testicular tumors].
    Le Tourneau C; Mignot L
    Rev Prat; 2006 Jan; 56(2):185-90. PubMed ID: 16584048
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of tumor markers in the treatment of germ cell tumor].
    Niwakawa M; Tobisu K
    Gan To Kagaku Ryoho; 2001 Aug; 28(8):1159-65. PubMed ID: 11525037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
    Marcillac I; Troalen F; Bidart JM; Ghillani P; Ribrag V; Escudier B; Malassagne B; Droz JP; Lhommé C; Rougier P
    Cancer Res; 1992 Jul; 52(14):3901-7. PubMed ID: 1377600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor volume, CT scan, lymphography, sonography, intravenous pyelography, and tumor markers in testis tumors.
    Wilbert DM; Klose KJ; Alken P; Jacobi GH; Hohenfellner R
    Urol Int; 1989; 44(1):15-9. PubMed ID: 2473563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
    Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
    Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour markers.
    Pandha HS; Waxman J
    QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant intracranial germ cell tumor treated with chemotherapy and radiotherapy without histopathological confirmation].
    Vervenne WL; Bakker PJ; Stalpers LJ; Bosch DA
    Ned Tijdschr Geneeskd; 2000 Mar; 144(11):527-31. PubMed ID: 10735140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.